Home > Income Statement > IPCA LABORATORIES

IPCA LABORATORIES
Revenue

    Back to Income Statement
IPCA LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for IPCA LABORATORIES
Please provide your vote to see the results

IPCA LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹8,897 Cr₹7,662 Cr₹6,204 Cr₹5,797 Cr₹5,395 Cr

What is the latest Revenue of IPCA LABORATORIES ?

The latest Revenue ratio of IPCA LABORATORIES is ₹8,897 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹8,897 Cr
Mar2025₹7,662 Cr
Mar2024₹6,204 Cr
Mar2023₹5,797 Cr
Mar2022₹5,395 Cr

How is Revenue of IPCA LABORATORIES Trending?

Years Revenue % Change
Mar2026 ₹8,897 Cr
16.11
Mar2025 ₹7,662 Cr
23.50
Mar2024 ₹6,204 Cr
7.03
Mar2023 ₹5,797 Cr
7.45
Mar2022 ₹5,395 Cr -

Compare Revenue of peers of IPCA LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
IPCA LABORATORIES ₹49,268.5 Cr -0.4% 0.2% 53.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹459,497.0 Cr 5.2% 4.3% 8% Stock Analytics
DIVIS LABORATORIES ₹294,146.0 Cr 3.6% 7.6% 50.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,474.0 Cr 3.4% 0.7% 32.6% Stock Analytics
DR REDDYS LABORATORIES ₹114,349.0 Cr 2.3% 14% 13.6% Stock Analytics
CIPLA ₹113,989.0 Cr 2% 6% -6.7% Stock Analytics


IPCA LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
IPCA LABORATORIES

-0.4%

0.2%

53.3%

SENSEX

7%

11.5%

-3.5%


You may also like the below Video Courses